Olmesartan Medoxomil/Amlodipine/Hydrochlorothiazide Accord (Olmesartan Medoxomil, Amlodipine, Hydrochlorothiazide)

Olmesartan medoxil, the active ingredient in Olmesartan Medoxomil/Amlodipine/Hydrochlorothiazide Accord, is a combination antihypertensive presented as a tablet for oral use. It treats high blood pressure in adults, often when single‑drug therapy does not provide adequate control.

GNH USA supplies Olmesartan Medoxomil/Amlodipine/Hydrochlorothiazide Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Olmesartan Medoxomil/Amlodipine/Hydrochlorothiazide Accord is used in the management of hypertension, acting on the renin‑angiotensin system and vascular smooth‑muscle tone. - Hypertension: lowers systolic and diastolic blood pressure when monotherapy is insufficient. - Hypertensive urgency: provides gradual blood‑pressure reduction as part of a stepped‑care approach. - Cardiovascular risk reduction: contributes to decreased risk of stroke and myocardial infarction in patients with elevated blood pressure.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Headache: mild to moderate intensity. - Peripheral edema: swelling of ankles or feet. - Dizziness or light‑headedness, especially after standing. - Fatigue: general feeling of tiredness. - Gastrointestinal discomfort: nausea or abdominal pain.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure causing fainting. - Electrolyte imbalance: significant changes in potassium or sodium levels. - Acute kidney injury: sudden decline in renal function. - Angio‑edema: rapid swelling of lips, tongue, or airway. - Liver enzyme elevation: abnormal liver function tests.

Before initiating therapy, consider patient‑specific factors and monitor appropriately. - Renal function: assess creatinine clearance and adjust if necessary. - Electrolytes: monitor potassium and sodium levels regularly. - Pregnancy: avoid use; drug is contraindicated in the third trimester. - Concomitant antihypertensives: watch for additive blood‑pressure lowering effects. - Elderly patients: start at lower dose and titrate cautiously. - Store at ambient temperature: keep below 25°C, in the original packaging, protected from moisture.

Olmesartan Medoxomil/Amlodipine/Hydrochlorothiazide Accord can interact with several medicines; clinical judgment is required.

Major Interactions (Avoid): - Aliskiren: combined use with ACE inhibitors or ARBs in diabetes or renal impairment increases risk of renal dysfunction. - Potassium‑sparing diuretics or supplements: may cause dangerous hyper‑kalaemia. - NSAIDs (high dose): can blunt antihypertensive effect and worsen renal function.

Moderate Interactions (Monitor Closely): - Lithium: may increase serum lithium levels, requiring concentration monitoring. - CYP3A4 inhibitors (e.g., itraconazole, clarithromycin): can raise amlodipine concentrations. - Antidiabetic agents: enhanced glucose‑lowering effect may necessitate dose adjustment.